Cargando…
Trimetazidine mitigates high glucose-induced retinal endothelial dysfunction by inhibiting PI3K/Akt/mTOR pathway-mediated autophagy
Trimetazidine (TMZ), as a metabolic regulator, has been widely testified to exhibit positive therapeutic effects on various disease models, but its role in diabetic retinopathy has not been reported. Therefore, this study was designed with the purpose of exploring the effects of TMZ on high-glucose...
Autores principales: | Yang, Qingsong, Li, Sizhen, Zhou, Zixiu, Yang, Xiaodong, Liu, Yating, Hao, Kuanxiao, Fu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974130/ https://www.ncbi.nlm.nih.gov/pubmed/35259050 http://dx.doi.org/10.1080/21655979.2022.2048993 |
Ejemplares similares
-
Gastrodin protects retinal ganglion cells from ischemic injury by activating phosphatidylinositol 3-kinase/protein kinase B/nuclear factor erythroid 2-related factor 2 (PI3K/AKT/Nrf2) signaling pathway
por: Li, Sizhen, et al.
Publicado: (2022) -
Genetic Association Study Revealed Three Loci Were Associated Risk of Myopia Among Minors
por: Zhou, Zixiu, et al.
Publicado: (2021) -
Association of n-3 polyunsaturated fatty acid intakes with juvenile myopia: A cross-sectional study based on the NHANES database
por: Zhou, Zixiu, et al.
Publicado: (2023) -
Trimetazidine ameliorates sunitinib-induced cardiotoxicity in mice via the AMPK/mTOR/autophagy pathway
por: Yang, Yi, et al.
Publicado: (2019) -
Silica nanoparticles induce autophagy and endothelial dysfunction via the PI3K/Akt/mTOR signaling pathway
por: Duan, Junchao, et al.
Publicado: (2014)